Terms: = Uterine cancer AND LCK, YT16, 3932, P06239, ENSG00000182866, p56lck, pp58lck AND Treatment
4 results:
1. lck facilitates DNA damage repair by stabilizing RAD51 and BRCA1 in the nucleus of chemoresistant ovarian cancer.
Dey G; Bharti R; Braley C; Alluri R; Esakov E; Crean-Tate K; McCrae K; Joehlin-Price A; Rose PG; Lathia J; Gong Z; Reizes O
J Ovarian Res; 2023 Jun; 16(1):122. PubMed ID: 37370140
[TBL] [Abstract] [Full Text] [Related]
2. Hospital resource utilisation from HPV-related diseases in England: a real-world cost analysis.
Fabiano G; Marcellusi A; Mennini FS; Sciattella P; Favato G
Eur J Health Econ; 2023 Feb; 24(1):75-80. PubMed ID: 35551568
[TBL] [Abstract] [Full Text] [Related]
3. Pretreatment with lck inhibitors chemosensitizes cisplatin-resistant endometrioid ovarian tumors.
Crean-Tate KK; Braley C; Dey G; Esakov E; Saygin C; Trestan A; Silver DJ; Turaga SM; Connor EV; DeBernardo R; Michener CM; Rose PG; Lathia J; Reizes O
J Ovarian Res; 2021 Apr; 14(1):55. PubMed ID: 33888137
[TBL] [Abstract] [Full Text] [Related]
4. Identification of novel prognosis-related genes in the endometrial cancer immune microenvironment.
Ma J; Zhang JK; Yang D; Ma XX
Aging (Albany NY); 2020 Nov; 12(21):22152-22173. PubMed ID: 33159014
[TBL] [Abstract] [Full Text] [Related]
